CHD

Church & Dwight

$97.73

+1.01%
Oct 8, 2026
Bobby Quantitative Model
Church & Dwight Co., Inc. is a leading global consumer packaged goods company best known as the world's largest producer of baking soda, with a diversified portfolio spanning laundry products, cat litter, oral care, deodorant, and nasal care, primarily marketed under its flagship Arm & Hammer brand alongside Batiste, OxiClean, Hero, and TheraBreath. The company operates in the Household & Personal Products industry within the Consumer Defensive sector, deriving roughly 80% of sales from the United States, and has expanded its reach through strategic acquisitions such as Touchland's hand sanitizer business in fiscal 2025. As a defensive staples name with a market capitalization of approximately $20-22 billion and only 5,550 employees, Church & Dwight is viewed by investors as a high-quality, cash-generative compounder with a track record of consistent dividend payments and brand-building. The current investor narrative centers on the company's ability to sustain mid-single-digit organic growth amid a challenging consumer environment, the integration of recent acquisitions, and whether its premium valuation relative to peers can be justified by its portfolio of power brands and international expansion potential.

People also watch

Procter & Gamble

Procter & Gamble

PG

Analysis
Colgate-Palmolive Company

Colgate-Palmolive Company

CL

Analysis
Kenvue

Kenvue

KVUE

Analysis
Estée Lauder Companies

Estée Lauder Companies

EL

Analysis
Kimberly-Clark

Kimberly-Clark

KMB

Analysis

BobbyInvestment Opinion: Should I buy CHD Today?

The synthesized recommendation is Hold, with a thesis that Church & Dwight is a high-quality defensive compounder with strong cash flow and margin expansion, but its premium valuation and low revenue growth limit near-term upside. The analyst consensus rating of 'buy' (mean 2.24) and average target price of $105.11 imply 11.5% upside, which is solid but not compelling enough to justify a strong buy given the risks. The stock's low beta of 0.472 makes it suitable for risk-averse investors seeking stability, but the 1.57% revenue growth rate is a significant constraint.

Supporting evidence for the Hold rating includes the trailing PE of 27.58x, which is at a premium to the broader market and typical consumer staples peers, though it sits in the lower half of the stock's recent historical range of 25.64x to 34.94x. The forward PE of 23.37x implies expected earnings growth, with consensus EPS of $4.83 versus trailing EPS of $3.42. Gross margin expanded 240 basis points year-over-year to 45.35% in Q2 2026, and free cash flow of $1.115 billion comfortably covers the 1.41% dividend yield and share repurchases. However, the price-to-sales ratio of 3.28x and EV/EBITDA of 17.04x are elevated relative to peers, and the 1.57% revenue growth is well below the industry average for defensive staples.

The biggest risks that could invalidate the thesis are a continued deceleration in revenue growth below 1%, margin compression if input costs rise or competitive pressures intensify, and a valuation multiple contraction if the premium is not justified by growth. The rating would upgrade to Buy if revenue growth accelerates above 3% or if the PE compresses below 22x, and it would downgrade to Sell if revenue growth turns negative or if gross margins fall below 43%. Relative to its history and peers, the stock appears fairly valued to slightly overvalued, with the premium justified only if margin expansion continues and acquisitions contribute meaningfully to growth.

Sign up to view all

CHD 12-Month Price Forecast

Church & Dwight presents a balanced risk-reward profile, with strong cash flow and margin expansion offset by low revenue growth and a premium valuation. The neutral stance reflects the lack of a clear catalyst to accelerate growth above 2%, which is necessary to justify multiple expansion. The stock's low beta and defensive characteristics make it suitable for risk-averse investors, but the 11.5% upside to the average analyst target is not compelling enough for a bullish stance. I would upgrade to bullish if revenue growth accelerates above 3% or if the company announces a major accretive acquisition, and downgrade to bearish if gross margins fall below 43% or if revenue growth turns negative.

Historical Price
Current Price $97.73
Average Target $102.50
High Target $115.00
Low Target $78.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Church & Dwight's 12-month outlook, with a consensus price target around $104.84 and implied upside of +7.3% versus the current price.

Average Target

$104.84

0 analysts

Implied Upside

+7.3%

vs. current price

Analyst Count

—

covering this stock

Price Range

$78 - $115

Analyst target range

Church & Dwight is covered by 19 analysts, with a consensus recommendation of "buy" and a recommendation mean of 2.24 (on a scale where 1 is Strong Buy and 5 is Strong Sell), indicating a moderately bullish tilt. The average price target is $105.11, which implies approximately 11.5% upside from the current price of $94.31, a solid but not spectacular return potential that reflects the stock's defensive characteristics and modest growth outlook. The consensus EPS estimate for the current year is $4.83, with a tight range of $4.78 to $4.90, suggesting high confidence in near-term earnings stability. The bullish consensus is notable given the stock's recent underperformance, and the implied upside suggests analysts see the recent pullback as a buying opportunity rather than the start of a deeper decline. The target price range spans from a low of $78.00 to a high of $115.00, a wide spread of 47.4% that signals significant disagreement among analysts about the company's prospects. The high target of $115 assumes successful integration of acquisitions, accelerating organic growth, and potential multiple expansion, while the low target of $78 prices in margin compression, competitive pressures, or a consumer slowdown that would disproportionately impact a premium-valued staples name. Recent institutional ratings show a mix of views: RBC Capital maintains an Outperform rating, Wells Fargo is Overweight, while Barclays remains Underweight and several firms (TD Cowen, Citigroup, UBS, JP Morgan) hold Neutral ratings, indicating that the bullish case is not universally shared. The wide target spread and the presence of both Outperform and Underweight ratings suggest that the stock's valuation premium is a key point of contention, and the direction of future revisions will likely depend on whether the company can accelerate revenue growth above the current 1.57% pace.

Drowning in data?

Find the real signal!

Bulls vs Bears: CHD Investment Factors

The bull case rests on margin expansion, strong free cash flow, and a low-beta defensive profile, while the bear case centers on decelerating revenue growth, relative underperformance, and a premium valuation that may not be justified by low-single-digit top-line growth. Currently, the bear evidence appears slightly stronger given the 1.57% revenue growth rate, negative short-term momentum, and persistent underperformance versus the S&P 500. The single most important tension is whether Church & Dwight can accelerate organic growth above 2-3% through successful acquisition integration and international expansion, or whether it remains a low-growth compounder whose premium multiple compresses toward peer levels. If growth remains stuck below 2%, the stock could struggle to justify its 27.58x trailing PE, but if margins continue to expand and acquisitions contribute meaningfully, the valuation could be sustained or even expand.

Bullish

  • Margin expansion accelerating: Q2 2026 gross margin expanded 240 basis points year-over-year to 45.35% from 42.95%, while net margin rose to 13.25% from 12.68%. This demonstrates pricing power and cost control despite only 1.57% revenue growth.
  • Strong free cash flow generation: Trailing twelve-month free cash flow stands at $1.115 billion, comfortably covering the 38.98% dividend payout ratio and funding $300 million in share repurchases. The price-to-free-cash-flow ratio of 16.74x is attractive for a defensive compounder.
  • Analyst consensus sees upside: With 19 analysts covering the stock, the consensus recommendation is 'buy' (mean 2.24) and the average price target of $105.11 implies 11.5% upside from the current $94.31. The high target of $115 suggests 22% potential upside if growth accelerates.
  • Low beta defensive profile: Beta of 0.472 means the stock is roughly 53% less volatile than the broader market, making it an attractive holding during periods of market turbulence. This low correlation supports portfolio diversification benefits.

Bearish

  • Revenue growth decelerating sharply: Q2 2026 revenue grew only 1.57% year-over-year to $1.53 billion, a significant slowdown from the 4.2% growth implied in the prior-year comparison. This low-single-digit pace is insufficient to justify a premium valuation without margin expansion.
  • Relative underperformance persists: The stock has gained 6.69% over the past year versus the S&P 500's 15.01% advance, a relative shortfall of 8.32 percentage points. Over the past six months, relative strength versus SPY is -15.78%, indicating sustained capital rotation away from this name.
  • Premium valuation vulnerable to compression: The EV/EBITDA of 17.04x and price-to-sales of 3.28x are elevated relative to typical consumer staples peers trading at 12-15x EV/EBITDA. With revenue growth below 2%, the premium is at risk if margins fail to expand further.
  • Recent momentum has turned negative: The stock is down 5.04% over the past month and 4.35% over the past three months, diverging from the positive year-to-date gain of 14.12%. This short-term weakness suggests a loss of upside momentum after a strong first-half run.

CHD Technical Analysis

Church & Dwight is in a broad recovery phase, with the stock up 6.69% over the past year and 14.12% year-to-date, though it remains 11.1% below its 52-week high of $106.04 and 15.9% above its 52-week low of $81.33. At the current price of $94.31, the stock is trading at approximately 57.7% of its 52-week range, positioning it in the middle-to-upper portion of its annual band, which suggests neither an overextended momentum chase nor a deep-value falling knife scenario. The 1-year gain of 6.69% significantly trails the S&P 500's 15.01% advance, indicating persistent relative underperformance that has kept the stock range-bound rather than in a sustained uptrend. Recent momentum has turned negative, with the stock down 5.04% over the past month and 4.35% over the past three months, diverging sharply from the positive 1-year and YTD trends. This short-term weakness contrasts with the 6-month gain of 1.57%, suggesting a loss of upside momentum after a strong first-half run, and the relative strength versus SPY is negative across all recent windows (-5.63% for 1-month, -7.69% for 3-month, -15.78% for 6-month), confirming that capital has rotated away from this defensive name. The divergence between the positive YTD trend (+14.12%) and the negative 1-month and 3-month trends (-5.04% and -4.35%) signals a potential trend reversal or at minimum a meaningful mean-reversion pullback, with the stock giving back a portion of its earlier gains. Key technical support lies near the 52-week low of $81.33, while resistance is established at the 52-week high of $106.04; a breakdown below the $93-94 area (where the stock has recently found footing) could open the door to a retest of the $90 level and potentially the $81.33 low, whereas a breakout above $100 would signal renewed bullish momentum toward the highs. The stock's beta of 0.472 indicates it is roughly 53% less volatile than the broader market, making it a low-beta defensive holding that typically appeals to risk-averse investors but may lag in strong bull markets, which is consistent with its underperformance versus SPY over the past year.

Beta

0.48

0.48x market volatility

Max Drawdown

-14.8%

Largest decline past year

52-Week Range

$81-$106

Price range past year

Annual Return

+9.9%

Cumulative gain past year

PeriodCHD ReturnS&P 500
1m+1.2%+1.0%
3m+1.4%+2.5%
6m+2.4%+13.9%
1y+9.9%+15.0%
ytd+18.3%+13.5%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

CHD Fundamental Analysis

Church & Dwight's revenue trajectory is modestly positive but decelerating, with Q2 2026 revenue of $1.53 billion representing 1.57% year-over-year growth from $1.506 billion in Q2 2025, a slowdown from the 4.2% growth implied by the prior-year comparison. The multi-quarter trend shows revenue oscillating between $1.47 billion and $1.64 billion, with Q1 2026 at $1.469 billion and Q4 2025 at $1.644 billion, indicating a business that is growing but at a low-single-digit pace typical of mature consumer staples. Segment data reveals that Consumer Domestic dominates with $1.156 billion in revenue, followed by Consumer International at $297.5 million and Specialty Products at $76.7 million, meaning the domestic business is the primary growth engine and any weakness there would disproportionately impact overall results. The modest growth rate implies the investment case rests more on margin expansion and cash returns than on top-line acceleration, and the company's ability to integrate acquisitions like Touchland will be critical to sustaining even low-single-digit growth. Profitability remains solid, with Q2 2026 net income of $202.8 million on a 13.25% net margin, up from $191 million and a 12.68% net margin in Q2 2025, demonstrating meaningful year-over-year margin expansion. Gross margin improved to 45.35% in Q2 2026 from 42.95% in the prior-year quarter, a 240 basis point gain that reflects favorable pricing, mix, and input cost dynamics, while the operating margin of 18.07% is healthy for the household products industry. The company's trailing gross margin of 44.73% and operating margin of 17.37% are consistent with a premium consumer staples profile, and the sequential improvement from Q4 2025's 8.73% net margin (which was depressed by a $77.9 million other-expense charge) to Q2 2026's 13.25% shows the underlying earnings power is intact. Church & Dwight's balance sheet is conservatively managed, with a debt-to-equity ratio of 0.55 and a current ratio of 1.07, indicating adequate but not abundant short-term liquidity. The company generated $1.115 billion in trailing twelve-month free cash flow, a robust figure that comfortably covers its dividend payments (payout ratio of 38.98%) and provides ample capacity for acquisitions and share repurchases, as evidenced by $300 million in stock repurchases in Q3 and Q4 2025. Return on equity of 18.41% and return on assets of 7.87% demonstrate efficient capital deployment, while the cash flow-to-debt ratio of 0.118 (based on quarterly operating cash flow of $286.8 million) suggests the company could deleverage quickly if needed. The Q2 2026 cash flow statement shows $286.8 million in operating cash flow, $29.9 million in capex, and $160.7 million deployed for acquisitions, highlighting a balanced capital allocation strategy that funds growth while returning cash to shareholders.

Quarterly Revenue

$1.5B

2026-06

Revenue YoY Growth

+1.6%

YoY Comparison

Gross Margin

45.4%

Latest Quarter

Free Cash Flow

$1.1B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Consumer Domestic
Consumer International
Specialty Products

Open an Account, get $2 TSLA now!

Valuation Analysis: Is CHD Overvalued?

Because Church & Dwight is profitable with trailing net income of approximately $745 million (sum of the last four quarters), the PE ratio is the appropriate primary valuation metric. The stock trades at a trailing PE of 27.58x and a forward PE of 23.37x, with the 15.3% gap between these figures implying the market expects meaningful earnings growth over the next twelve months, consistent with the consensus EPS estimate of $4.83 versus trailing EPS of approximately $3.42. The PEG ratio of 1.01 suggests the stock is fairly valued relative to its expected growth rate, which is a reasonable outcome for a high-quality defensive name. Compared to the broader Household & Personal Products industry, Church & Dwight's trailing PE of 27.58x represents a premium, though the exact industry average is not provided in the data; however, the company's price-to-sales ratio of 3.28x and EV/EBITDA of 17.04x are elevated relative to typical consumer staples peers, which often trade at 12-15x EV/EBITDA. This premium is partially justified by Church & Dwight's superior gross margin of 44.73%, strong free cash flow generation, and portfolio of leading brands, but the low revenue growth rate of 1.57% makes the premium vulnerable to compression if growth does not accelerate. The price-to-book ratio of 5.08x is also rich, reflecting the asset-light nature of the branded consumer goods business and the substantial goodwill from acquisitions. Historically, Church & Dwight's PE ratio has ranged from a low of around 21.96x (Q3 2021) to a high of 39.42x (Q4 2021), with more recent quarters showing a range of 25.64x to 34.94x. The current trailing PE of 27.58x sits in the lower half of this recent historical band, suggesting the stock is not expensive by its own standards and may offer value if earnings continue to grow. However, the PS ratio of 3.28x is near the low end of its historical range (which has been as high as 18.59x in Q1 2022, though that figure appears distorted by a different share count or data methodology), and the price-to-free-cash-flow ratio of 16.74x is attractive relative to the company's cash generation. The current valuation appears to price in modest growth expectations, and any acceleration in revenue or margin expansion could drive multiple expansion toward the higher end of the historical range.

PE

27.6x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 22x~38x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

17.0x

Enterprise Value Multiple

Investment Risk Disclosure

Church & Dwight faces financial and operational risks primarily stemming from its low revenue growth and dependence on margin expansion. With Q2 2026 revenue growing only 1.57% year-over-year, the company has limited top-line cushion to absorb unexpected cost pressures or competitive pricing actions. The debt-to-equity ratio of 0.55 and current ratio of 1.07 indicate adequate but not abundant liquidity, and the company deployed $160.7 million for acquisitions in Q2 2026, which could strain the balance sheet if integration underperforms. Additionally, the consumer domestic segment accounts for $1.156 billion of the $1.53 billion quarterly revenue, creating concentration risk where a slowdown in the U.S. market would disproportionately impact overall results. The Q4 2025 net margin of 8.73% was depressed by a $77.9 million other-expense charge, highlighting earnings volatility from non-operating items.

Market and competitive risks include valuation compression if growth fails to accelerate, given the stock trades at 27.58x trailing earnings and 17.04x EV/EBITDA, both at a premium to typical consumer staples peers. The beta of 0.472 means the stock is less sensitive to broad market swings, but this also means it may lag in strong bull markets, as evidenced by its 8.32 percentage point underperformance versus the S&P 500 over the past year. Competitive disruption from private-label brands and larger rivals like Procter & Gamble could pressure pricing and market share, particularly in the laundry and oral care categories. Regulatory headwinds, such as potential changes to trade policies or ingredient regulations, could also impact costs, though no specific recent news highlights an immediate threat.

The worst-case scenario would involve a consumer spending slowdown that forces retailers to reduce inventory, leading to volume declines and margin compression. If revenue growth turns negative and margins contract, the stock could retest its 52-week low of $81.33, representing a 13.8% decline from the current price of $94.31. The analyst low target of $78 implies a 17.3% downside, and the historical max drawdown of -14.82% suggests that a decline of 15-20% from current levels is plausible in a severe adverse scenario. In this case, an investor could lose approximately 14-17% from the current price, with the $78-81 range serving as a realistic downside target if growth stalls and valuation multiples compress toward peer averages.

FAQ

The most severe risk is revenue growth deceleration, as Q2 2026 growth of 1.57% is already low and could turn negative if consumer spending weakens or competition intensifies. Financial risks include a debt-to-equity ratio of 0.55 and a current ratio of 1.07, which provide adequate but not abundant liquidity, and the company's $160.7 million acquisition spending could strain the balance sheet if integration fails. Market risks include valuation compression, as the stock's premium multiples could contract toward peer averages if growth does not accelerate, and the low beta of 0.472 means it may lag in strong bull markets. Company-specific risks include concentration in the U.S. market (80% of sales) and dependence on the Arm & Hammer brand, which accounts for a significant portion of sales and profits.

The 12-month forecast includes a base case with 55% probability, targeting $100-105, assuming revenue growth of 1.5-2.5% and stable margins. The bull case has a 25% probability, targeting $110-115, driven by successful acquisition integration and multiple expansion. The bear case has a 20% probability, targeting $78-85, if revenue growth stalls and margins compress. The most likely scenario is the base case, with the key assumption that Church & Dwight maintains low-single-digit growth and continues to generate strong free cash flow. The analyst average target of $105.11 aligns with the base case, implying 11.5% upside from the current price of $94.31.

Church & Dwight trades at a trailing PE of 27.58x and a forward PE of 23.37x, which is at a premium to the broader market and typical consumer staples peers. The EV/EBITDA of 17.04x is elevated compared to the 12-15x range for many peers, and the price-to-sales ratio of 3.28x is also high. However, the PEG ratio of 1.01 suggests the stock is fairly valued relative to its expected earnings growth, and the PE is in the lower half of its recent historical range of 25.64x to 34.94x. The market is pricing in modest growth expectations, and the premium is justified only if margin expansion continues and acquisitions contribute meaningfully. Relative to its own history, the stock appears fairly valued, but relative to peers, it is slightly overvalued.

Church & Dwight offers a balanced risk-reward profile, with 11.5% upside to the average analyst target of $105.11 and a low beta of 0.472 that appeals to risk-averse investors. However, revenue growth of only 1.57% year-over-year and a premium valuation of 27.58x trailing earnings limit the upside potential. The stock is a good buy for income-focused investors seeking stability and a 1.41% dividend yield, but growth-oriented investors may find better opportunities elsewhere. The biggest downside risk is a retest of the 52-week low of $81.33, representing a 13.8% decline, if growth stalls or margins compress. Overall, it is a hold for most investors, with a buy case only if revenue growth accelerates above 3%.

Church & Dwight is best suited for long-term investment, given its defensive characteristics, low beta of 0.472, and consistent dividend payments with a 38.98% payout ratio. The stock's low volatility and stable cash flows make it appropriate for conservative portfolios focused on capital preservation and income. Short-term trading is less attractive due to the lack of near-term catalysts and the stock's recent negative momentum, down 5.04% over the past month. A minimum holding period of 2-3 years is recommended to allow for the integration of acquisitions and potential acceleration in organic growth. The stock's 1-year return of 6.69% trails the S&P 500, so investors should expect modest but steady returns rather than rapid appreciation.